Inflammation resolution: Does the bone marrow have a say?
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake
Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia
Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis
A method for the continuous calculation of the age of labeled red blood cells
Variation and heritability of Hb F and F-cells among β-thalassemia heterozygotes in Hong Kong
Hematological abnormalities in patients with distal renal tubular acidosis and hemoglobinopathies
Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation
A scoring system for the classification of β-thalassemia/Hb E disease severity
Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria
Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy
HIV-associated multicentric Castleman’s disease
Seeing what isn’t there
Lysis and thrombosis: Manifestation of the same disease
Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: A case series
Isolated extramedullary relapse presenting as autologous lymphocyte response
Leukoerythroblastic anemia due to oxalosis with extensive bone marrow involvement
brain natriuretic peptide level as marker of cardiac function in imatinib—treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy
Mutations are no substitutes for clotting, chromogenic and immunological assays in patients with congenital prothrombin deficiency
Response to Girolami et al.
Clinical JAK2 V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations
Partial splenic embolization preceding splenectomy, in a case of refractory immune thrombocytopenic purpura